Pacira BioSciences (PCRX) EBIT (2010 - 2026)
Pacira BioSciences' EBIT was $4.27 million in Q2 2026, down 49.8% from $8.5 million a year earlier and down 38.2% from the prior quarter.
Powered by 
Analysis
Pacira BioSciences (PCRX) EBIT (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Pacira BioSciences' EBIT was $19.87 million through Jun 30, 2026; for FY2025, it was $19.19 million.
- EBIT shows a five-year compound annual growth rate of -16.2% (FY2020 to FY2025).
- In earlier years, EBIT was -$73.37 million in FY2024, $87.68 million in FY2023 (+46.1%), $60.02 million in FY2022 (-33.3%) and $89.92 million in FY2021 (+94.0%).
- Quarterly EBIT has moved between -$139.53 million (Q3 2024) and $39.88 million (Q2 2023) over five years.
- Compared with a year earlier, EBIT was higher in 1 of the last six quarters, with an average decline of 12.3%.
- The best year-over-year quarter for EBIT over five years was Q1 2026 (growth of 246.8%); the worst was Q4 2025 (a decline of 90.5%).
- Per Business Quant data, PCRX's EBIT in the three quarters before Q2 2026 was $6.9 million (Q1 2026), $2.34 million (Q4 2025) and $6.36 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Pacira BioSciences | 1.01 Bn | 73.12 Mn | 148.24 Mn | 4.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.27 Mn |
| Mar 31, 2026 | 6.90 Mn |
| Dec 31, 2025 | 2.34 Mn |
| Sep 30, 2025 | 6.36 Mn |
| Jun 30, 2025 | 8.50 Mn |
| Mar 31, 2025 | 1.99 Mn |
| Dec 31, 2024 | 24.70 Mn |
| Sep 30, 2024 | -139.53 Mn |
| Jun 30, 2024 | 28.24 Mn |
| Mar 31, 2024 | 13.21 Mn |
| Dec 31, 2023 | 33.17 Mn |
| Sep 30, 2023 | 17.72 Mn |
| Jun 30, 2023 | 39.88 Mn |
| Mar 31, 2023 | -3.09 Mn |
| Dec 31, 2022 | -9.89 Mn |
| Sep 30, 2022 | 21.29 Mn |
| Jun 30, 2022 | 31.24 Mn |
| Mar 31, 2022 | 17.39 Mn |
| Dec 31, 2021 | 4.21 Mn |
| Sep 30, 2021 | 31.43 Mn |
API Access
Pacira BioSciences EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=PCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "PCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=PCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();